Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 201

Results For "UP"

7697 News Found

Incyte eyes first-line nod for Tafasitamab in aggressive lymphoma
News | January 07, 2026

Incyte eyes first-line nod for Tafasitamab in aggressive lymphoma

Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma (NHL) in adults, represents 40% of all cases worldwide


MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial
Biotech | January 07, 2026

MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial

Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit


Medera doses final patient in high-dose HFpEF gene therapy trial
Biopharma | January 07, 2026

Medera doses final patient in high-dose HFpEF gene therapy trial

Heart failure affects an estimated 64.3 million people worldwide


Valneva and Serum Institute end chikungunya vaccine partnership
News | January 06, 2026

Valneva and Serum Institute end chikungunya vaccine partnership

Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries


Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer
People | January 06, 2026

Thyrocare appoints Rajdeep Panwar as Chief Commercial Officer

Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector


PHARMEXCIL holds high-level talks with government to boost India’s pharma exports
News | January 06, 2026

PHARMEXCIL holds high-level talks with government to boost India’s pharma exports

India’s pharmaceutical sector stands at a pivotal inflection point


Corewell Health, Quest Diagnostics finalize Michigan Lab JV
R&D | January 06, 2026

Corewell Health, Quest Diagnostics finalize Michigan Lab JV

The state-of-the-art laboratory opens at the Corewell Health Southfield Center in early 2027


Dabur sees early demand recovery, rural sales lead growth in Q3 FY26
News | January 06, 2026

Dabur sees early demand recovery, rural sales lead growth in Q3 FY26

Within India, Dabur expects its Home & Personal Care business to deliver double-digit growth,


RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects
Clinical Trials | January 06, 2026

RedHill Biopharma advances RHB-102 as once-daily oral therapy to combat GLP-1 side effects

The company is pursuing the accelerated FDA 505(b)(2) approval pathway for its once-daily oral ondansetron formulation


PathoCare Holdings valued at $1.75 billion following major third-party tender offer
News | January 06, 2026

PathoCare Holdings valued at $1.75 billion following major third-party tender offer

The company previously completed a $150 million venture investment, acquisition, and recapitalization